Target | HIKMA PHARMACEUTICALS PLC |
---|---|
Bidder | INSTITUTIONAL INVESTORS |
Price | £80.00 Full version or £25.00 Light version |
Publication Date | Jun 22, 2020 |
Abstract | On 22 July 2020, the German pharmaceutical group Boehringer Ingelheim Invest GmbH ("Boehringer Ingelheim") announced that it intended to sell approximately 28 million ordinary shares (an 11.51% stake) in Hikma Pharmaceuticals Plc ("Hikma") by way of an accelerated bookbuild offering to institutional investors. Concurrently with the placing, Hikma had committed to buy back ... |
Number of pages (Full version) | 8 |
Number of pages (Light version) | 2 |
Format | Adobe Acrobat (Download Acrobat Reader) |
Free Sample | Click Here to Download |
Buy and download this report in a fast a safe way using our secure payment system. We accept all major credit cards.